Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention Of Endometrial Tumours (POET)
2006-001815-30Phase 3Terminated
- Sponsor
- St George's, University of London
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of avatrombopag in endometrial cancer (EC), Endometrial intraepithelial neoplasia (EIN) and hereditary nonpolyposis colorectal cancer (HNPCC), sponsored by St George's, University of London. Primary endpoint: Detection of atypical endometrial hyperplasia or cancer. Started May 2006; status: terminated.
02
Drugs
avatrombopag
03
Conditions
endometrial cancer (EC)Endometrial intraepithelial neoplasia (EIN)hereditary nonpolyposis colorectal cancer (HNPCC)
Beyond the preview
Go deeper on 2006-001815-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001815-30.